No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
As a pioneer in Korea's pharmaceutical landscape, Daihan Pharmaceutical Co., Ltd. was the first to produce infusions, a crucial innovation that significantly contributed to national public health. This initial achievement not only forged new pathways for other medical companies but also solidified its standing as a leading domestic manufacturer of intravenous solutions.
www.daihan.com/engNo one on the platform currently holds 023910.KS.
No tracked institution reports a position in 023910.KS as of their last filing.
No one on the platform has traded 023910.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 023910.KSDaihan Pharmaceutical Co. | $25800.00 | -1.15% | $151.7B | — |
| 002210.KSDong Sung Bio Pharm.Co.,Ltd. | $1367.00 | +0.07% | $33.4B | — |
| 007575.KSIlyang Pharmaceutical Co.,Ltd | $7540.00 | -0.13% | $154.0B | — |
| 182400.KQNKMAX Co. Ltd. | $2020.00 | +0.00% | $172.7B | — |
| 241820.KQPCL, Inc. | $302.00 | -1.63% | $15.5B | — |
| 268600.KQCellivery Therapeutics, Inc. | $6680.00 | +0.00% | $248.4B | — |
| 294090.KQEOFLOW Co.,Ltd. | $1490.00 | -5.64% | $50.8B | — |
Source: Financial Modeling Prep · peers by sector/industry